We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Lawyers are advising devicemakers preparing conflict mineral reports due to the Securities and Exchange Commission this month to put more effort into describing their compliance with the Organisation for Economic Co-operation and Development’s due diligence guidelines. Read More
U. S. industry group AdvaMed has hung up its shingle in Shanghai, aiming to play a more proactive role in regulatory and reimbursement policies impacting devicemakers in China. Read More
Rumors of a Medtronic/Covidien merger were confirmed last week with the announcement that Medtronic will pay $42.9 billion in cash and stock for the Dublin-based devicemaker. Read More
Prices for medical technologies grew on average just 1 percent per year over the past two decades, noticeably slower than other U.S. costs, new AdvaMed research shows. Read More